Poland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Dostawa produktów leczniczych

The subject of the contract includes 31 lots (Lot No. 1-30 – medicinal products) Lot No. 1: Tafasitamab Lot No. 2: Avatrombopag Lot No. 3: Ibrutinib Lot No. 4: Daratumumab Lot No. 5: Avapritinib Lot No. 6: Ribociclib Lot No. 7: Alpelisib Lot No. 8: Darolutamide Lot No. 9: Gilteritinib Lot No. 10: Sotorasib Lot No. 11: Tucatinib Lot No. 12: Trastuzumab deruxtecan Lot No. 13: Isatuximab Lot No. 14: Zanubrutinib Lot No. 15: Esketamine Lot No. 16: Dostarlimab Lot No. 17: Caplacizumab Lot No. 18: Fruquintinib Lot No. 19: Tremelimumab Lot No. 20: Tislelizumab Lot No. 21: Amivantamab Lot No. 22: Lazertinib Lot No. 23: Serplulimab Lot No. 24: Binimetinib Lot No. 25: Encorafenib Lot No. 26: Capivasertib Lot No. 27: Mosunetuzumab Lot No. 28: Glofitamab Lot No. 29: Cabozantinib Lot No. 30: Immunoglobulins Lot No. 31: Immunoglobulins - secondary immunodeficiency